Journal
BIOMOLECULES
Volume 11, Issue 9, Pages -Publisher
MDPI
DOI: 10.3390/biom11091380
Keywords
EBV; latency; reactivation; stress; vaccination
Categories
Funding
- National Institutes of Health [R01AI144112, R01AI146917]
Ask authors/readers for more resources
EBV is often latent in immunocompetent individuals, but perturbations in the host immune system can lead to viral reactivation and various related illnesses. Understanding the interaction between the virus, stress, and the immune system is crucial for effective treatment.
Epstein-Barr virus (EBV) is typically found in a latent, asymptomatic state in immunocompetent individuals. Perturbations of the host immune system can stimulate viral reactivation. Furthermore, there are a myriad of EBV-associated illnesses including various cancers, post-transplant lymphoproliferative disease, and autoimmune conditions. A thorough understanding of this virus, and the interplay between stress and the immune system, is essential to establish effective treatment. This review will provide a summary of the interaction between both psychological and cellular stressors resulting in EBV reactivation. It will examine mechanisms by which EBV establishes and maintains latency and will conclude with a brief overview of treatments targeting EBV.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available